Principle and evolving role of intraperitoneal chemotherapy in ovarian cancer

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.14, Iss.13, 2013-09, pp. : 1797-1806

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Counterpoint: Intraperitoneal Chemotherapy: An Investigational Treatment in Ovarian Cancer

By Ozols Robert F.

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 2, Iss. 6, 2004-11 ,pp. : 555-560

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Point: Intraperitoneal Chemotherapy in the Management of Ovarian Cancer

By Markman Maurie

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 2, Iss. 6, 2004-11 ,pp. : 549-554

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Intraperitoneal Chemotherapy for Ovarian Cancer: Where Are We Now?

By Singhal Pankaj Lele Shashikant

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 4, Iss. 9, 2006-10 ,pp. : 941-946

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Intraperitoneal Chemotherapy as First-Line Treatment in the Management of Epithelial Ovarian Cancer

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 5, 2007-05 ,pp. : 511-519

Bentham Science Publishers

Access to resources Recommend Favorite

Survival Benefit of Adding Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) at the Different Time-points of Treatment of Ovarian Cancer: Review of Evidence

Current Pharmaceutical Design, Vol. 18, Iss. 25, 2012-07 ,pp. : 3793-3803

Bentham Science Publishers

Access to resources Recommend Favorite